Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2016Blood

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRamón García‐SánzHospital General Universitario Gregorio MarañónASAnna SuredaInstitut d'Investigació Biomédica de BellvitgeAGAna Pilar GonzálezHebron University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

García‐Sánz et al. (2016) studied this question.

synapsesocial.com/papers/6a4ddb214bfb440195c20c52https://doi.org/10.1182/blood.v128.22.1109.1109
View Full Paper
Ask AI
Bookmark
Share